Bioscience

Cyplasin Biomedical & Virionics Corp. announce letter of intent for reverse takeover

November 19, 2009

By Flinn Foundation

Cyplasin Biomedical Ltd.  announced today that it has entered into an irrevocable Letter of Intent (LOI) with Arizona -based Virionics Corporation, to effect a reverse take over of 100% of the Company.

For more information: Cyplasin Biomedical Ltd., and Virionics Corporation, announces Letter of Intent (LOI) for Reverse Takeover (RTO), Name Change and Related Financings